Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.49B |
| 2 |
NVIDIA
NVDA
|
+$2.19B |
| 3 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.94B |
| 4 |
TSMC
TSM
|
+$728M |
| 5 |
UnitedHealth
UNH
|
+$705M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$775M |
| 2 |
AbbVie
ABBV
|
+$540M |
| 3 |
Delta Air Lines
DAL
|
+$434M |
| 4 |
Eli Lilly
LLY
|
+$433M |
| 5 |
DexCom
DXCM
|
+$433M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.89% |
| 2 | Healthcare | 2.92% |
| 3 | Financials | 2.71% |
| 4 | Consumer Discretionary | 2.52% |
| 5 | Industrials | 2.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
12351
CLPS Inc
CLPS
$25.9M
| $15.8K | ﹤0.01% |
+19,515
| New | +$18K |
|
|
BBLG
12352
Bone Biologics
BBLG
$1.76M
| $15.7K | ﹤0.01% |
+10,844
| New | +$21.6K |
|
|
TBHC
12353
PUT
DELISTED
The Brand House Collective
TBHC
| $15.1K | ﹤0.01% |
+13,700
| New | +$19K |
|
12354
CALL
Talphera
TLPH
$71.6M
| $15K | ﹤0.01% |
13,200
-2,200
| -14% | -$2.65K |
|
12355
Zhongchao
ZCMD
$6.53M
| $15K | ﹤0.01% |
45
+20
| +80% | +$10.3K |
|
12356
Bullfrog AI
BFRG
$11.5M
| $15K | ﹤0.01% |
16,937
+1,912
| +13% | +$2.23K |
|
|
BYAH
12357
Park Ha Biological Technology Co
BYAH
$2.15M
| $14.9K | ﹤0.01% |
+1,877
| New | +$28.5K |
|
|
ZTEK
12358
Zentek
ZTEK
$78.6M
| $14.9K | ﹤0.01% |
+23,240
| New | +$17.8K |
|
|
DKI
12359
DarkIris Inc
DKI
$7.75M
| $14.4K | ﹤0.01% |
+2,777
| New | +$24.8K |
|
|
QUCY
12360
Quantum Cyber N.V.
QUCY
$34.2M
| $14.2K | ﹤0.01% |
+12,643
| New | +$16.6K |
|
|
GMHS
12361
Gamehaus Holdings
GMHS
$46.1M
| $14.1K | ﹤0.01% |
+15,319
| New | +$17.4K |
|
12362
PUT
Rackspace Technology
RXT
$1.29B
| $14.1K | ﹤0.01% |
14,500
+1,100
| +8% | +$1.38K |
|
12363
Trio Petroleum
TPET
$11.6M
| $13.8K | ﹤0.01% |
+17,405
| New | +$16.5K |
|
12364
bioAffinity Technologies
BIAF
$3.52M
| $13.7K | ﹤0.01% |
+11,631
| New | +$23.2K |
|
|
NVNO
12365
enVVeno Medical
NVNO
$7.36M
| $13.7K | ﹤0.01% |
1,221
-345
| -22% | -$6.7K |
|
12366
PUT
Vivani Medical
VANI
$121M
| $13.5K | ﹤0.01% |
+11,000
| New | +$15.9K |
|
|
APLT
12367
PUT
DELISTED
Applied Therapeutics
APLT
| $13.5K | ﹤0.01% |
135,000
-33,500
| -20% | -$21.3K |
|
12368
PUT
Skye Bioscience
SKYE
$20.4M
| $13.5K | ﹤0.01% |
+18,000
| New | +$26.3K |
|
12369
Ohmyhome Ltd
OMH
$3.2M
| $13.4K | ﹤0.01% |
16,571
-1,167
| -7% | -$1.23K |
|
12370
CALL
Harvard Bioscience
HBIO
$28.4M
| $12.9K | ﹤0.01% |
1,930
-2,310
| -54% | -$13.7K |
|
12371
Urban One Class A
UONE
$24M
| $12.9K | ﹤0.01% |
+1,250
| New | +$15.4K |
|
12372
AEON Biopharma
AEON
$13.2M
| $12.8K | ﹤0.01% |
+11,642
| New | +$10.9K |
|
|
NCT
12373
Intercont (Cayman) Ltd
NCT
$34M
| $12.7K | ﹤0.01% |
+2,653
| New | +$55.5K |
|
12374
PUT
Agilon Health
AGL
$1.5B
| $12.5K | ﹤0.01% |
724
-4,988
| -87% | -$96.7K |
|
|
MRNO
12375
Murano Global Investments
MRNO
$17.3M
| $12.4K | ﹤0.01% |
+21,407
| New | +$42.2K |
|
Similar funds
Citadel Advisors's Q4 2025 Portfolio in Review
As of Q4 2025, Citadel Advisors held 14,701 positions worth $666B, up 1.3% from $657B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors's Q4 2025 filing shows 2,078 new, 5,000 increased, 5,363 reduced and 2,191 closed positions. Its largest new stake was Medline Inc: 6,006,339 shares worth $252M. The largest sale was Meta Platforms (Facebook), an estimated $775M.
By sector, the portfolio is most concentrated in Technology at 4.9% of assets, up from 3.8% a quarter earlier, followed by Healthcare and Financials.
- Citadel Advisors's largest Q4 2025 buy was Medline Inc: 6,006,339 shares worth $252M.
- Citadel Advisors added most to Amazon in Q4 2025, an estimated $2.49B increase.
- Citadel Advisors's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $775M.
- Citadel Advisors fully exited WEX in Q4 2025, selling an estimated $131M.
- Citadel Advisors's ten largest holdings make up 23% of its $666B portfolio in Q4 2025.
- Citadel Advisors opened 2,078 new positions and closed 2,191 in Q4 2025.
- Citadel Advisors's portfolio value rose 1.3% quarter-over-quarter to $666B.
Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.